Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Evaluation of the Effectiveness and Safety of Dupilumab in Bullous Pemphigoid: An Ambispective Multicenter Case Series.
Planella-Fontanillas N, Bosch-Amate X, Jiménez Antón A, Moreno-Vílchez C, Guerrero MG, Del Mar Blanes Martínez M, Ballester Martínez MA, Bassas-Freixas P, Castaño Fernández JL, Estébanez Corrales A, Suarez Fernández R, Santos Alarcón S, Alonso AB, Torrent M, Ballano Ruiz A, Collantes Rodríguez C, España A, Fonseca Capdevila E, Faure IG, Hernández Fernández CP, Melgosa Ramos FJ, Spertino J, Zaragoza Ninet V, Armillas L, Bielsa I, Carrera C, Rafat ME, Fulgencio Barbarin J, Fernandez Vela J, Lova Navarro M, Callizo CM, Martín-Sala S, Ojeda R, Amer MEP, Puigdollers AS, Pujol RM, Podlipnik S, Mascaró JM Jr, Curto-Barredo L. Planella-Fontanillas N, et al. Among authors: amer mep. Br J Dermatol. 2024 Oct 17:ljae403. doi: 10.1093/bjd/ljae403. Online ahead of print. Br J Dermatol. 2024. PMID: 39418120
Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
Berenguer J, González-García J, López-Aldeguer J, Von-Wichmann MA, Quereda C, Hernando A, Sanz J, Tural C, Ortega E, Mallolas J, Santos I, Miralles P, Montes ML, Bellón JM, Esteban H; GESIDA HIV/HCV cohort. Berenguer J, et al. J Antimicrob Chemother. 2009 Jun;63(6):1256-63. doi: 10.1093/jac/dkp106. Epub 2009 Apr 10. J Antimicrob Chemother. 2009. PMID: 19363085 Clinical Trial.
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Berenguer J, Alvarez-Pellicer J, Martín PM, López-Aldeguer J, Von-Wichmann MA, Quereda C, Mallolas J, Sanz J, Tural C, Bellón JM, González-García J; GESIDA3603/5607 Study Group. Berenguer J, et al. Hepatology. 2009 Aug;50(2):407-13. doi: 10.1002/hep.23020. Hepatology. 2009. PMID: 19575364